Project Grant DP2AI184552
Award Date
8/15/24
Completion Date
7/31/29
Dollars Obligated
$503K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Yale Univ (FL6GV84CKN57)
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
West Haven, CT 06516, USA
Similar Awards
This $780,162 Project Grant from the National Institutes of Health's National Institute of Allergy and Infectious Diseases will fund research at Old Dominion University from August 2022 through July 2026 exploring the role of nutrient and stress sensing in regulating Clostridioides difficile physiology and behavior within the host. The research aims to determine how the stringent response regulates disease-relevant bacterial processes and characterize enzymes that mediate alarmone metabolism...
This $2,237,543 federal Project Grant award was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant will fund a quantitative investigation of the pathogen-microbiome-host dynamics of clinically prominent Clostridioides difficile (C. diff) lineages and their contribution to C. diff infection (CDI). The research aims to: 1) Investigate pangenome determinants of CDI risk in clinically...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $1,541,024.00 to the University of Notre Dame to support research on the spore germination pathway of the bacterium Clostridioides difficile (C. difficile) and its pharmacological intervention. The research aims to elucidate the details of the spore germination process, demonstrate that inhibiting spore germination is key to preventing...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $261,492 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the Trustees of Tufts College (Tufts University School of Medicine) to support research on the epigenetic regulation of sporulation in Clostridioides difficile, a major nosocomial pathogen. The project aims to identify specific methylation sites that mediate the epigenetic regulation of sporulation in C. difficile, which could facilitate...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) is for the development of novel antibiotic therapies targeting Clostridioides difficile infection (CDI). The $754,446 award aims to: Optimize a lead series of inhibitors targeting the essential bacterial enzyme FabK, with the goal of improving antimicrobial potency and selectivity against C. difficile. Identify new chemical...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a 2-year, $171,254 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the Nimml Institute Inc., a non-profit research organization in Blacksburg, Virginia. The grant supports research aimed at elucidating novel immunometabolic mechanisms that can intercept bacterial toxin internalization and processing to suppress cell damage caused by Clostridioides difficile infection (CDI). Specifically, the...
The University of North Carolina at Chapel Hill (UNC-CH) was awarded a $521,030 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The goal of this 5-year grant, with a period of performance from November 2024 to October 2029, is to define the interplay between stochastic and regulatory mechanisms underlying the heterogeneous expression of flagella and toxins in Clostridioides difficile, a...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), is funding research to enhance the understanding of Clostridioides difficile (C. diff) infection epidemiology and optimize C. diff surveillance strategies. The $272,140 award will support the following key activities over the project period from June 2024 to February 2025: Applying molecular epidemiologic approaches...
This $894,552 project grant from the National Institutes of Health's National Institute of Allergy and Infectious Diseases Allergy and Infectious Diseases Research program (CFDA 93.855) will fund research at the University of Nevada, Las Vegas to probe the effect of a high-fat/high-protein diet on Clostridioides difficile infection. Specifically, the researchers will examine how such a diet impacts inflammation, intestinal permeability, and the gut microbiome before and after antibiotic...
This $222,852 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research at the University of North Carolina at Chapel Hill to investigate the role of the Rho transcription termination factor in regulating Clostridioides difficile virulence factors. The key objectives of this 3-year project are to: 1) Identify and annotate Rho, NusA, and NusG-dependent transcriptional...